These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2613842)

  • 21. [Cholinergic crisis in a patient with myasthenia treated by plasma exchange and anticholinesterase agents].
    Pourrat O; Robert R; Neau JP; Deleplanque P; Alcalay D
    Ann Med Interne (Paris); 1988; 139 Suppl 1():51-2. PubMed ID: 3247993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of myasthenia gravis].
    Szobor A; Klein M
    Psychiatr Neurol Med Psychol (Leipz); 1976 Jan; 28(1):33-42. PubMed ID: 940881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of methylprednisolone and methylprednisolone 21-[8-[methyl-(2-sulfoethyl)amino]-8-oxooctanoate] sodium salt in human urine by high-performance liquid chromatography with ultraviolet detection.
    Shah JA; Weber DJ
    J Chromatogr; 1989 Nov; 496(2):245-54. PubMed ID: 2515202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversed-phase ion-pair high-performance liquid chromatographic determination of triclabendazole metabolites in serum and urine.
    Negro A; Alvarez-Bujidos ML; Ortiz AI; Cubría JC; Méndez R; Ordóñez D
    J Chromatogr; 1992 Apr; 576(1):135-41. PubMed ID: 1500447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 26. [HOW TO TREAT MYASTHENIA].
    LAPRESLE J; BOUDIN G; GOULON M; HAMBURGER J; LHERMITTE F; PEQUIGNOT H
    Presse Med (1893); 1964 Oct; 72():2459-62. PubMed ID: 14214765
    [No Abstract]   [Full Text] [Related]  

  • 27. [MYASTHENIAS: THYMECTOMY AND SPIRONOLACTONES].
    DEVIC M; THIVOLET J; MICHET F; LENGLET JP; MAILLET P
    Rev Otoneuroophtalmol; 1964; 36():169-74. PubMed ID: 14219300
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract]   [Full Text] [Related]  

  • 29. On the treatment of myasthenia gravis.
    Szobor A
    Acta Med Acad Sci Hung; 1969; 26(2):103-19. PubMed ID: 5792196
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229 nm) detection.
    Zhong WZ; Lakings DB
    J Chromatogr; 1989 May; 490(2):377-85. PubMed ID: 2768410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative determination of the gamma-aminobutyric acid agonist, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol, in serum by high-performance liquid chromatography.
    Madsen SM
    J Chromatogr; 1983 May; 274():209-18. PubMed ID: 6874822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 33. Liquid chromatographic analysis of clonazepam in human serum with solid-phase (Bond-Elut) extraction.
    Kabra PM; Nzekwe EU
    J Chromatogr; 1985 Jun; 341(2):383-90. PubMed ID: 4030987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative care after thymectomy for myasthenia gravis.
    Prazák M; Placák B
    Int Surg; 1969 May; 51(5):388-94. PubMed ID: 5781286
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenia gravis and pregnancy.
    Chambers DC; Hall JE; Boyce J
    Obstet Gynecol; 1967 Apr; 29(4):597-603. PubMed ID: 6067025
    [No Abstract]   [Full Text] [Related]  

  • 36. Solid-phase extraction of fluoropyrimidine derivatives on a copper-modified strong cation exchanger: determination of doxifluridine, 5-fluorouracil and its main metabolites in serum by high-performance liquid chromatography with ultraviolet detection.
    Guerrieri A; Palmisano F; Zambonin PG; De Lena M; Lorusso V
    J Chromatogr; 1993 Jul; 617(1):71-7. PubMed ID: 8376540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification.
    Osserman KE; Genkins G
    Ann N Y Acad Sci; 1966 Jan; 135(1):312-34. PubMed ID: 5221347
    [No Abstract]   [Full Text] [Related]  

  • 38. High performance liquid chromatographic determination of levomepromazine in human breast milk and serum using solid phase extraction.
    Ohkubo T; Shimoyama R; Sugawara K
    Biomed Chromatogr; 1993; 7(4):227-8. PubMed ID: 8219702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On anti-myasthenic activity of an oxamide derivative (Win 8077)].
    GENTILI C; LOPERFIDO E
    Arch Ital Sci Farmacol; 1959 Oct; 9():517-28. PubMed ID: 13827329
    [No Abstract]   [Full Text] [Related]  

  • 40. Clonazepam serum levels in epileptic patients determined simply and rapidly by high-performance liquid chromatography using a solid-phase extraction column.
    Furuno K; Gomita Y; Araki Y; Fukuda T
    Acta Med Okayama; 1991 Apr; 45(2):123-7. PubMed ID: 1867113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.